Related references
Note: Only part of the references are listed.First hemophilia B gene therapy approved: More than two decades in the making
Roland W. Herzog et al.
MOLECULAR THERAPY (2023)
Adeno-Associated Virus Gene Therapy for Hemophilia
Benjamin J. Samelson-Jones et al.
ANNUAL REVIEW OF MEDICINE (2023)
Hemophilia A Gene Therapy - Some Answers, More Questions
Lindsey A. George
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Hemophilia Gene Therapy: The End of the Beginning?
Dries De Wolf et al.
HUMAN GENE THERAPY (2023)
Altered cleavage of human factor VIII at the B-domain and acidic region 3 interface enhances expression after gene therapy in hemophilia A mice
Giang N. Nguyen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)
Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia A
P. Batty et al.
BLOOD (2022)
Bispecific antibodies for the treatment of hemophilia A
Midori Shima
EXPERT OPINION ON BIOLOGICAL THERAPY (2022)
Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A
Sylvia Fong et al.
NATURE MEDICINE (2022)
Vector genome loss and epigenetic modifications mediate decline in transgene expression of AAV5 vectors produced in mammalian and insect cells
Britta Handyside et al.
MOLECULAR THERAPY (2022)
Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics
Vuokko Nummi et al.
HAEMOPHILIA (2022)
Heterogeneity and reciprocity of FVIII and VWF expression, and the response to shear stress in cultured human endothelial cells
Christine Hough et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
Structural insights into blood coagulation factor VIII: Procoagulant complexes, membrane binding, and antibody inhibition
Kenneth C. Childers et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV- transduced hepatocytes in hemophilia A mice
John S. S. Butterfield et al.
MOLECULAR THERAPY (2022)
First conditional marketing authorization approval in the European Union for hemophilia A gene therapy
Thierry VandenDriessche et al.
MOLECULAR THERAPY (2022)
Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma
Audrey Kapelanski-Lamoureux et al.
MOLECULAR THERAPY (2022)
Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice
Dhwanil A. Dalwadi et al.
MOLECULAR THERAPY (2021)
Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A
Lindsey A. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Hemophilia A (Factor VIII Deficiency)
Craig D. Seaman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Hemophilia Gene Therapy: Approaching the First Licensed Product
Paul Batty et al.
HEMASPHERE (2021)
Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulum
Juthakorn Poothong et al.
BLOOD (2020)
Hemophilia therapy: the future has begun
Pier Mannuccio Mannucci
HAEMATOLOGICA (2020)
Mechanisms, regulation and functions of the unfolded protein response
Claudio Hetz et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?
Glenn F. Pierce et al.
HAEMOPHILIA (2020)
A reprieve from hemophilia A, but for how long?
Cormac Sheridan
NATURE BIOTECHNOLOGY (2020)
Minimal Essential Human Factor VIII Alterations Enhance Secretion and Gene Therapy Efficiency
Wenjing Cao et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Induction of ER Stress by an AAV5 BDD FVIII Construct Is Dependent on the Strength of the Hepatic-Specific Promoter
Sylvia Fong et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
K. John Pasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy
Benjamin J. Samelson-Jones et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Hsp70 molecular chaperones: multifunctional allosteric holding and unfolding machines
Eugenia M. Clerico et al.
BIOCHEMICAL JOURNAL (2019)
Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males A Meta-analytic Approach Using National Registries
Alfonso Iorio et al.
ANNALS OF INTERNAL MEDICINE (2019)
The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: Getting by with a little help from ERdj friends
Kristine Faye R. Pobre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis
Boris Brumshtein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A
G. N. Nguyen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Expression and characterization of a codon-optimized blood coagulation factor VIII
S. A. Shestopal et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Bispecific Antibody Therapy in Hemophilia
David Lillicrap
NEW ENGLAND JOURNAL OF MEDICINE (2017)
AAV5-Factor VIII Gene Transfer in Severe Hemophilia A
Savita Rangarajan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape
Federico Mingozzi et al.
ANNUAL REVIEW OF VIROLOGY, VOL 4 (2017)
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A
Daniela Melchiorre et al.
HAEMATOLOGICA (2016)
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A
Daniela Melchiorre et al.
HAEMATOLOGICA (2016)
Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches
Shannon L. Meeks et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Overexpression of factor VIII after AAV delivery is transiently associated with cellular stress in hemophilia A mice
Amy M. Lange et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Potential for cellular stress response to hepatic factor VIII expression from AAV vector
Irene Zolotukhin et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models
Joshua I. Siner et al.
JCI INSIGHT (2016)
Murine coagulation factor VIII is synthesized in endothelial cells
Lesley A. Everett et al.
BLOOD (2014)
ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
Hayato Nakagawa et al.
CANCER CELL (2014)
Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype
Joshua I. Siner et al.
BLOOD (2013)
Molecular approaches for improved clotting factors for hemophilia
Randal J. Kaufman et al.
BLOOD (2013)
ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death
Jaeseok Han et al.
NATURE CELL BIOLOGY (2013)
Defects in IRE1 enhance cell death and fail to degrade mRNAs encoding secretory pathway proteins in the Arabidopsis unfolded protein response
Kei-ichiro Mishiba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Quantitative correlation between transcriptional levels of ER chaperone, peroximal protein and FVIII productivity in human Hek-293 cell line
Evandra Strazza Rodrigues et al.
SPRINGERPLUS (2013)
Codon optimization of human factor VIII cDNAs leads to high-level expression
Natalie J. Ward et al.
BLOOD (2011)
Enhanced Biosynthesis of Coagulation Factor VIII through Diminished Engagement of the Unfolded Protein Response
Harrison C. Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Phosphorylation of eIF2 Facilitates Ribosomal Bypass of an Inhibitory Upstream ORF to Enhance CHOP Translation
Lakshmi Reddy Palam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
Bart R. Anderson et al.
NUCLEIC ACIDS RESEARCH (2010)
Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model
Denise E. Sabatino et al.
BLOOD (2009)
IRE1α Kinase Activation Modes Control Alternate Endoribonuclease Outputs to Determine Divergent Cell Fates
Dan Han et al.
CELL (2009)
Chop deletion reduces oxidative stress, improves β cell function, and promotes cell survival in multiple mouse models of diabetes
Benbo Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Antioxidants reduce endoplasmic reticulum stress and improve protein secretion
Jyoti D. Malhotra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IRE1 signaling affects cell fate during the unfolded protein response
Jonathan H. Lin et al.
SCIENCE (2007)
ATF6α optimizes long-term endoplasmic reticulum function to protect cells from chronic stress
Jun Wu et al.
DEVELOPMENTAL CELL (2007)
Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV
Sarah C. Darby et al.
BLOOD (2007)
AAV vector integration sites in mouse hepatocellular carcinoma
Anthony Donsante et al.
SCIENCE (2007)
ReFacto®1 and Advate®2:: a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia A
J. Di Paola et al.
HAEMOPHILIA (2007)
Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins
D. Thomas Rutkowski et al.
PLOS BIOLOGY (2006)
Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response
Julie Hollien et al.
SCIENCE (2006)
The promise and challenges of bioengineered recombinant clotting factors
SW Pipe
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Identification of porcine coaglulation factor VIII domains responsible for high level expression via enhanced secretion
CB Doering et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum
SJ Marciniak et al.
GENES & DEVELOPMENT (2004)
XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation
AL Shaffer et al.
IMMUNITY (2004)
Bioengineering of coagulation factor VIR for improved secretion
HZ Miao et al.
BLOOD (2004)
Sustained phenotypic correction of canine hemophilia A using an adeno-associated viral vector
CD Scallan et al.
BLOOD (2003)
Structure-function relationships in factor IX and factor IXa
AE Schmidt et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2003)
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A
JM Lusher et al.
HAEMOPHILIA (2003)
IREI-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response
K Lee et al.
GENES & DEVELOPMENT (2002)
IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA
M Calfon et al.
NATURE (2002)
Manufacturing challenges in the commercial production of recombinant coagulation factor VIII
R Jiang et al.
HAEMOPHILIA (2002)
ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs
J Ye et al.
MOLECULAR CELL (2000)
Regulated translation initiation controls stress-induced gene expression in mammalian cells
HP Harding et al.
MOLECULAR CELL (2000)
Ligand-independent dimerization activates the stress response kinases IRE1 and PERK in the lumen of the endoplasmic reticulum
CY Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response
A Bertolotti et al.
NATURE CELL BIOLOGY (2000)
ATP-dependent dissociation of non-disulfide-linked aggregates of coagulation factor VIII is a rate-limiting step for secretion
L Tagliavacca et al.
BIOCHEMISTRY (2000)
Share Paper
